fda import alert glp-1 semaglutide tirzepatide green list Getting the Light: FDA's New Safeguards for Imports Compounded Semaglutide & Tirzepatide 2025:

We source our peptides exclusively from licensed, U.S.-based compounding pharmacies

The narrative format was selected to accommodate heterogeneous evidence spanning preclinical mechanisms, clinical trials, and translational barriers where systematic synthesis would be inappropriate

This way, your medication can be safely monitored and administered

But consider how we think about other chronic conditions

On Cozen OConnors State AG Pulse podcast, State AG Group attorney Keturah Taylor spoke with Cozen OConnor colleagues Danielle Sapega and Rick Van Buren about federal and state GLP-1 regulation and enforcement, as well as a roadmap to help legitimate market participants avoid pitfalls